Clinical study malondialdehyde adduct to hemoglobin: a new marker of oxidative stress suitable for full-term and preterm neonates

HIGHLIGHTS

• who: Cécile Cipierre et al. from the Département de Néonatologie, CHU Angers, rue Larrey, Angers, France have published the Article: Clinical Study Malondialdehyde Adduct to Hemoglobin: A New Marker of Oxidative Stress Suitable for Full-Term and Preterm Neonates, in the Journal: (JOURNAL) of 13/04/2013
• what: The aim of this study was to evaluate a new marker the malondialdehyde adduct to hemoglobin (MDA-Hb) which is measured in red blood cells (RBCs) and thus does not require that an additional blood sample be drawn. As cord blood pH is systematically . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.